COLUMN-Little fresh evidence in new Allergan suit: FRANKEL

Mon Aug 4, 2014 5:52pm EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article | Single Page
[-] Text [+]

(The opinions expressed here are those of Alison Frankel, a columnist for Reuters.)

By Alison Frankel

NEW YORK Aug 4 (Reuters) - A few days after the Canadian pharmaceutical company Valeant announced that it had teamed up with the activist investor William Ackman to bid for Botox maker Allergan, Wachtell, Lipton, Rosen & Katz wrote a teeth-gnashing client alert about the new threat to corporate targets from the unholy alliance of a strategic bidder with an activist hedge fund.

Commentators were already raising questions about whether Ackman and Valeant had engaged in insider trading, because Ackman secretly accumulated Allergan shares based on his knowledge of Valeant's imminent takeover bid. But in that early memo, Wachtell didn't claim Valeant and Ackman had broken insider trading rules. Instead, the firm bemoaned Valeant and Ackman's "conspicuously structured" stratagem that "took express pains to sidestep" the Williams Act's bar on trading in advance of a tender offer.

Unfortunately for Allergan and future target companies, Wachtell said, "The structure is crafty, and good for Valeant and Pershing Square (as long as no bad facts emerge, such as undisclosed arrangements, that could get them in trouble)."

A prophetic parenthetical? On Friday, Wachtell - now acting as counsel to Allergan, along with Latham & Watkins - filed a complaint in federal court in Los Angeles that accuses Valeant and Ackman of executing an "improper and illicit insider-trading scheme ... flouting key provisions of the federal securities laws."

The suit not only claims that Valeant and Ackman didn't make adequate disclosures to Allergan shareholders - reviving an old takeover defense tactic from the 1980s - but also pushes the novel theory that Ackman violated a provision of the Williams Act prohibiting anyone except an acquirer from trading on material non-public knowledge that the acquirer has taken "a substantial step" toward launching a tender offer.

CASHING IN   Continued...